Veterinary Medicines

Marbosol 100 mg/ml solution for injection for cattle and pigs

Authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
Marbosol 100 mg/ml solution for injection for cattle and pigs
Marbosol 100 mg/ml oldatos injekció szarvasmarhák és sertések számára A.U.V.
Active substance:
  • Marbofloxacin
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Marbofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
  • Subcutaneous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
  • Intramuscular use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        72
        hour
      • Milk
        36
        hour
      • Meat and offal
        3
        day
    • Pig
      • Meat and offal
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:
  • (ID2) 100 millilitre(s): unspecified outer container with 1 Vial (Glass) with 100 millilitre(s)
  • (ID1) 50 millilitre(s): unspecified outer container with 1 Vial (Glass) with 50 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cp-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 3319/X/13 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0175/002
Concerned member states:
  • Hungary
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."